Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid
Status:
Unknown status
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of Sheng Bai oral liquid in
prevention and treatment of the decrease of neutrophilics after chemotherapy in patients with
non-small-cell lung cancer.